Sarcura

Klosterneuburg, Austria

Cell Therapy transformed cancer treatment. Sarcura will transform cell therapy manufacturing.

$7.3M raised

Nov 2022

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Sarcura raised?

Sarcura has raised $7.3M in total funding. The most recent round was Seed. The last funding was announced in November 2022.

Who are Sarcura's investors?

Sarcura's investors include Nina Capital, HCVC, XISTA Science Ventures, NovaCapital, tecnet equity.

Where is Sarcura headquartered?

Sarcura is headquartered in Klosterneuburg, Austria.

What does Sarcura do?

Cell Therapy transformed cancer treatment. Sarcura will transform cell therapy manufacturing.

What stage is Sarcura at?

Sarcura is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 17, 2022.

MLA

"Sarcura — Funding & Investors." VCBacked, November 17, 2022, https://www.vcbacked.co/company/sarcura. Accessed July 2, 2026.

APA

VCBacked. (2022). Sarcura — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/sarcura

Wikipedia (cite web)

{{cite web |title=Sarcura — Funding & Investors |url=https://www.vcbacked.co/company/sarcura |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 17, 2022.